Natixis’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,045
| Closed | -$56.3K | – | 1082 |
|
|
2024
Q1 | $56.3K | Sell |
2,045
-189
| -8% | -$5.2K | ﹤0.01% | 799 |
|
|
2023
Q4 | $68.1K | Sell |
2,234
-967
| -30% | -$29.5K | ﹤0.01% | 780 |
|
|
2023
Q3 | $101K | Buy |
+3,201
| New | +$101K | ﹤0.01% | 770 |
|
|
2023
Q2 | – | Sell |
-3,668
| Closed | -$137K | – | 1087 |
|
|
2023
Q1 | $137K | Sell |
3,668
-146
| -4% | -$5.44K | ﹤0.01% | 763 |
|
|
2022
Q4 | $133K | Sell |
3,814
-349
| -8% | -$12.2K | ﹤0.01% | 796 |
|
|
2022
Q3 | $238K | Sell |
4,163
-198
| -5% | -$11.3K | ﹤0.01% | 911 |
|
|
2022
Q2 | $222K | Sell |
4,361
-700
| -14% | -$35.6K | ﹤0.01% | 962 |
|
|
2022
Q1 | $368K | Sell |
5,061
-478
| -9% | -$34.8K | ﹤0.01% | 1030 |
|
|
2021
Q4 | $655K | Sell |
5,539
-584
| -10% | -$69.1K | ﹤0.01% | 986 |
|
|
2021
Q3 | $821K | Sell |
6,123
-43,885
| -88% | -$5.88M | ﹤0.01% | 930 |
|
|
2021
Q2 | $8.1M | Sell |
50,008
-211
| -0.4% | -$34.2K | 0.04% | 311 |
|
|
2021
Q1 | $4.03M | Buy |
50,219
+39,623
| +374% | +$3.18M | 0.01% | 557 |
|
|
2020
Q4 | $576K | Buy |
+10,596
| New | +$576K | ﹤0.01% | 881 |
|